Keywords: roche, initiates, ph, ii, trial, novel, hcv

Roche initiates Ph II trial of novel HCV drug

Article | 23 October 2006

Print This

Swiss drug major Roche has initiated the first Phase II study to evaluate its new polymerase inhibitor, R1626, for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in